menu
    • menu

    Company profile for Empress Therapeutics

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LEBSA- Your strategic API source for niche molecules.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Founded by Flagship Pioneering in 2020, Empress has built a proprietary product platform, called Chemilogics, to canvass the untapped universe within the human body of chemistry encoded in DNA and pioneer a new paradigm in small molecule drug discovery with tremendous potential value to patients and society. The company's proprietary bio platform harnesses the power of evolution, human molecular and genetic data, and artificia...
    Founded by Flagship Pioneering in 2020, Empress has built a proprietary product platform, called Chemilogics, to canvass the untapped universe within the human body of chemistry encoded in DNA and pioneer a new paradigm in small molecule drug discovery with tremendous potential value to patients and society. The company's proprietary bio platform harnesses the power of evolution, human molecular and genetic data, and artificial intelligence to discover advanced starting points in endogenous drug-like molecules, helping clinicians to treat a wide range of serious unmet medical needs with small molecule drug candidates.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Empress TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    790 Memorial Drive, Suite 2B Cambridge, MA 02139
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.empresstx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/empresstx/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Empress Announces Formation of World Leading Scientific Advisory Board
    Empress Announces Formation of World Leading Scientific Advisory Board

    23 Jan 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240123299458/en

    BUSINESSWIRE
    23 Jan 2024
    Share Share
    Empress Therapeutics emerges with $50m to fund small molecule development
    Empress Therapeutics emerges with $50m to fund small molecule development

    21 Jun 2023

    // Aidan McNamee PHARMACEUTICAL TECHNOLOGY

    https://www.pharmaceutical-technology.com/news/empress-therapeutics-emerges-with-50m-to-fund-small-molecule-development/

    Aidan McNamee PHARMACEUTICAL TECHNOLOGY
    21 Jun 2023
    Share Share
    Flagship Pioneering Unveils Empress to Revolutionize Drug Discovery
    Flagship Pioneering Unveils Empress to Revolutionize Drug Discovery

    21 Jun 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/flagship-pioneering-unveils-empress-therapeutics-to-revolutionize-drug-discovery-by-applying-the-power-of-genetics-to-identify-small-molecule-drugs-301853175.html

    PR NEWSWIRE
    21 Jun 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search